We serve Chemical Name:3-Chloro-4,5-dimethoxybenzonitrile CAS:90537-30-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Chloro-4,5-dimethoxybenzonitrile
CAS.NO:90537-30-7
Synonyms:3-Chlor-4,5-dimethoxy-benzonitril;5-chloro-3,4-dimethoxybenzonitrile;5-Chlorveratronitril;5-Chlor-3.4-dimethoxy-benzoesaeure-nitril;3-chloro-4,5-dimethoxy-benzonitrile;MFCD02256340
Molecular Formula:C9H8ClNO2
Molecular Weight:197.61800
HS Code:2926909090
Physical and Chemical Properties:
Melting point:101-105ºC(lit.)
Boiling point:282.4ºC at 760mmHg
Density:1.26g/cm3
Index of Refraction:1.538
PSA:42.25000
Exact Mass:197.02400
LogP:2.22888
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 3-Chlor-4,5-dimethoxy-benzonitril chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD02256340 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Chlor-4,5-dimethoxy-benzonitril Use and application,3-chloro-4,5-dimethoxy-benzonitrile technical grade,usp/ep/jp grade.
Related News: The victim — who died Saturday — was a 44-year-Chinese man who flew in from Wuhan in January. 3-Chloro-4,5-dimethoxybenzonitrile manufacturer Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. 3-Chloro-4,5-dimethoxybenzonitrile supplier Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. 3-Chloro-4,5-dimethoxybenzonitrile vendor The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. 3-Chloro-4,5-dimethoxybenzonitrile factory Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment.
